These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 36788715)
1. Hybrid Closed Loop Using a Do-It-Yourself Artificial Pancreas System in Adults With Type 1 Diabetes. Nanayakkara N; Sharifi A; Burren D; Elghattis Y; Jayarathna DK; Cohen N J Diabetes Sci Technol; 2024 Jul; 18(4):889-896. PubMed ID: 36788715 [TBL] [Abstract][Full Text] [Related]
2. Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes. Ware J; Allen JM; Boughton CK; Wilinska ME; Hartnell S; Thankamony A; de Beaufort C; Schierloh U; Fröhlich-Reiterer E; Mader JK; Kapellen TM; Rami-Merhar B; Tauschmann M; Nagl K; Hofer SE; Campbell FM; Yong J; Hood KK; Lawton J; Roze S; Sibayan J; Bocchino LE; Kollman C; Hovorka R; N Engl J Med; 2022 Jan; 386(3):209-219. PubMed ID: 35045227 [TBL] [Abstract][Full Text] [Related]
3. Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial. McAuley SA; Lee MH; Paldus B; Vogrin S; de Bock MI; Abraham MB; Bach LA; Burt MG; Cohen ND; Colman PG; Davis EA; Hendrieckx C; Holmes-Walker DJ; Kaye J; Keech AC; Kumareswaran K; MacIsaac RJ; McCallum RW; Sims CM; Speight J; Stranks SN; Sundararajan V; Trawley S; Ward GM; Jenkins AJ; Jones TW; O'Neal DN; Diabetes Care; 2020 Dec; 43(12):3024-3033. PubMed ID: 33055139 [TBL] [Abstract][Full Text] [Related]
4. A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial. Tsoukas MA; Majdpour D; Yale JF; Fathi AE; Garfield N; Rutkowski J; Rene J; Legault L; Haidar A Lancet Digit Health; 2021 Nov; 3(11):e723-e732. PubMed ID: 34580055 [TBL] [Abstract][Full Text] [Related]
5. Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial. McAuley SA; Trawley S; Vogrin S; Ward GM; Fourlanos S; Grills CA; Lee MH; Alipoor AM; O'Neal DN; O'Regan NA; Sundararajan V; Colman PG; MacIsaac RJ Diabetes Care; 2022 Feb; 45(2):381-390. PubMed ID: 34844995 [TBL] [Abstract][Full Text] [Related]
6. Analysis of "Hybrid Closed Loop Using a Do-It-Yourself Artificial Pancreas System in Adults With Type 1 Diabetes". Wilkinson TM; de Bock M J Diabetes Sci Technol; 2024 Jul; 18(4):897-898. PubMed ID: 37850586 [TBL] [Abstract][Full Text] [Related]
7. Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial. Kim JY; Jin SM; Kang ES; Kwak SH; Yang Y; Yoo JH; Bae JH; Moon JS; Jung CH; Bae JC; Suh S; Moon SJ; Song SO; Chon S; Kim JH Diabetologia; 2024 Jul; 67(7):1235-1244. PubMed ID: 38634887 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of Android artificial pancreas system use at home among adults with type 1 diabetes mellitus in China: protocol of a 26-week, free-living, randomised, open-label, two-arm, two-phase, crossover trial. Lei M; Lin B; Ling P; Liu Z; Yang D; Deng H; Yang X; Lv J; Xu W; Yan J BMJ Open; 2023 Aug; 13(8):e073263. PubMed ID: 37558445 [TBL] [Abstract][Full Text] [Related]
9. Advanced Hybrid Closed Loop in Adult Population With Type 1 Diabetes: A Substudy From the ADAPT Randomized Controlled Trial in Users of Real-Time Continuous Glucose Monitoring. van den Heuvel T; Kolassa R; Keuthage W; Kroeger J; Ré R; de Portu S; Vorrink L; Shin J; Castañeda J; Vigersky R; Cohen O J Diabetes Sci Technol; 2024 Sep; 18(5):1132-1138. PubMed ID: 36949671 [TBL] [Abstract][Full Text] [Related]
10. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial. Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709 [TBL] [Abstract][Full Text] [Related]
12. Study protocol for a randomised open-label clinical trial examining the safety and efficacy of the Android Artificial Pancreas System (AAPS) with advanced bolus-free features in adults with type 1 diabetes: the 'CLOSE IT' (Closed Loop Open SourcE In Type 1 diabetes) trial. Wilkinson T; Tomic D; Boyle E; Burren D; Elghattis Y; Jenkins A; Keesing C; Middleton S; Nanayakkara N; Williman J; de Bock M; Cohen ND BMJ Open; 2024 Feb; 14(2):e078171. PubMed ID: 38382954 [TBL] [Abstract][Full Text] [Related]
13. Pre-school and school-aged children benefit from the switch from a sensor-augmented pump to an AndroidAPS hybrid closed loop: A retrospective analysis. Petruzelkova L; Jiranova P; Soupal J; Kozak M; Plachy L; Neuman V; Pruhova S; Obermannova B; Kolouskova S; Sumnik Z Pediatr Diabetes; 2021 Jun; 22(4):594-604. PubMed ID: 33576551 [TBL] [Abstract][Full Text] [Related]
14. DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home. Biester T; Nir J; Remus K; Farfel A; Muller I; Biester S; Atlas E; Dovc K; Bratina N; Kordonouri O; Battelino T; Philip M; Danne T; Nimri R Diabetes Obes Metab; 2019 Apr; 21(4):822-828. PubMed ID: 30478937 [TBL] [Abstract][Full Text] [Related]
15. Glucose Control in Adults with Type 1 Diabetes Using a Medtronic Prototype Enhanced-Hybrid Closed-Loop System: A Feasibility Study. Lee MH; Vogrin S; Paldus B; Jones HM; Obeyesekere V; Sims C; Wyatt SA; Ward GM; McAuley SA; MacIsaac RJ; Krishnamurthy B; Sundararajan V; Jenkins AJ; O'Neal DN Diabetes Technol Ther; 2019 Sep; 21(9):499-506. PubMed ID: 31264889 [No Abstract] [Full Text] [Related]
16. Safety and glycemic outcomes of do-it-yourself AndroidAPS hybrid closed-loop system in adults with type 1 diabetes. Gawrecki A; Zozulinska-Ziolkiewicz D; Michalak MA; Adamska A; Michalak M; Frackowiak U; Flotynska J; Pietrzak M; Czapla S; Gehr B; Araszkiewicz A PLoS One; 2021; 16(4):e0248965. PubMed ID: 33819289 [TBL] [Abstract][Full Text] [Related]
17. Closed-Loop Insulin Therapy for People With Type 2 Diabetes Treated With an Insulin Pump: A 12-Week Multicenter, Open-Label Randomized, Controlled, Crossover Trial. Borel AL; Lablanche S; Waterlot C; Joffray E; Barra C; Arnol N; Amougay H; Benhamou PY Diabetes Care; 2024 Oct; 47(10):1778-1786. PubMed ID: 39106206 [TBL] [Abstract][Full Text] [Related]
18. Fully Closed-Loop Glucose Control Compared With Insulin Pump Therapy With Continuous Glucose Monitoring in Adults With Type 1 Diabetes and Suboptimal Glycemic Control: A Single-Center, Randomized, Crossover Study. Boughton CK; Hartnell S; Lakshman R; Nwokolo M; Wilinska ME; Ware J; Allen JM; Evans ML; Hovorka R Diabetes Care; 2023 Nov; 46(11):1916-1922. PubMed ID: 37616583 [TBL] [Abstract][Full Text] [Related]
19. Hybrid Closed-Loop Versus Manual Insulin Delivery in Adults With Type 1 Diabetes: A Post Hoc Analysis Using the Glycemia Risk Index. Lee MH; Vogrin S; Jones TW; O'Neal DN J Diabetes Sci Technol; 2024 Jul; 18(4):764-770. PubMed ID: 38372246 [TBL] [Abstract][Full Text] [Related]
20. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier. Bruttomesso D; Farret A; Costa S; Marescotti MC; Vettore M; Avogaro A; Tiengo A; Dalla Man C; Place J; Facchinetti A; Guerra S; Magni L; De Nicolao G; Cobelli C; Renard E; Maran A J Diabetes Sci Technol; 2009 Sep; 3(5):1014-21. PubMed ID: 20144414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]